IL6 and COVID-19: As targeting IL-6 is a potential therapeutic strategy for COVID-19 (Y and R, 2021), our results showed that IL-6 targeted replicase-transcriptase complex (Nsp13), accessory factor (ORF8) and structural protein (E) (Figure 7B).